Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at the University of Florida is assessing zinc supplementation before Botox injections for spasmodic dysphonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZINC (Zinc chloride)

Snippet

Sponsor: University of Florida | Conditions: Spasmodic Dysphonia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING